Furthermore, the fact that BSA-nanocarrier-coated MSCs achieved only partial localization to sites of atherosclerosis demonstrates that upregulation of ICAM-1 levels alone is not sufficient to recruit unmodified MSCs into the aorta. Here, ICAM1 is linked to atherosclerosis.